Kit Simpson to Rituximab
This is a "connection" page, showing publications Kit Simpson has written about Rituximab.
Connection Strength
0.265
-
Ultralow-dose rituximab in pemphigus: a single-centre experience. Br J Dermatol. 2022 03; 186(3):581-583.
Score: 0.190
-
Cost-effectiveness of extended adjuvant rituximab for US patients aged 65-70 years with follicular lymphoma in second remission. Clin Lymphoma Myeloma. 2008 Jun; 8(3):166-70.
Score: 0.075